Experimental and Molecular Medicine (Jul 2018)

PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart

  • Somy Yoon,
  • Taewon Kook,
  • Hyun-Ki Min,
  • Duk-Hwa Kwon,
  • Young Kuk Cho,
  • Mira Kim,
  • Sera Shin,
  • Hosouk Joung,
  • Seung Hoon Jeong,
  • Sumin Lee,
  • Gaeun Kang,
  • Yunchul Park,
  • Yong Sook Kim,
  • Youngkeun Ahn,
  • Julie R. McMullen,
  • Ulrich Gergs,
  • Joachim Neumann,
  • Kyung Keun Kim,
  • Jungchul Kim,
  • Kwang-Il Nam,
  • Young-Kook Kim,
  • Hyun Kook,
  • Gwang Hyeon Eom

DOI
https://doi.org/10.1038/s12276-018-0121-2
Journal volume & issue
Vol. 50, no. 7
pp. 1 – 14

Abstract

Read online

Cardiovascular disease: A brake for heart muscle growth A regulatory mechanism that controls how cardiac muscle responds to stress could inform development of new therapies for preventing heart failure. Physiological stimuli ranging from heavy exercise to heart attack can induce hypertrophy, an increase in cardiac muscle mass that is initially beneficial but can lead to organ failure. Researchers led by Gwang Hyeon Eom and Hyun Kook at the Chonnam National University Biomedical Research Center, Hwasungun, South Korea have found that an enzyme called protein phosphatase 2A (PP2A) keeps cardiac hypertrophy in check. PP2A binds to and inhibits a second protein known as HDAC2, which would otherwise stimulate the hypertrophic response to stress. The researchers have identified the biochemical mechanism by which PP2A inactivates HDAC2, and demonstrate that this inhibition effectively protects against hypertrophic cardiac damage in mice, revealing a possible avenue for clinical intervention.